telotristat ethyl

FDA Drug Profile — Xermelo

telotristat ethyl is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Xermelo. Available dosage form: tablet.

Drug Details

Generic Name
telotristat ethyl
Brand Names
Xermelo
Application Number
NDA208794
Sponsor
Catalent Pharma Solutions, LLC
NDC Codes
4
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
TELOTRISTAT ETHYL

Indications and Usage

1 INDICATIONS AND USAGE Xermelo is indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. Xermelo is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. ( 1 )